Press Releases

Date	Title	Company
16-Feb-2023	Multiplex Biomarker Imaging Market is expected to reach US$ 1,041.7 Million by 2029	MARKITWIRED
16-Feb-2023	Monkeypox Treatment Market is expected to reach a valuation of US$ 93.84 million in 2023	MARKITWIRED
16-Feb-2023	Opioid Use Disorder Treatment Market is projected to reach US$ 8.4 billion by 2033	MARKITWIRED
16-Feb-2023	Pharmaceutical Filtration Market to reach a valuation of ~US$ 41.0 Billion by 2032	MARKITWIRED
16-Feb-2023	Animal Healthcare Market is expected to surpass US$ 62.3 billion by 2033	MARKITWIRED
16-Feb-2023	Eurofins Viracor Launches Ground-Breaking Test for Assessing Expansion and Persistence of CAR-T Therapy in Cancer Patients	Businesswire
16-Feb-2023	Allergy Diagnostics Market is predicted to grow at CAGR of 7.7% through 2033	MARKITWIRED
16-Feb-2023	Knee Reconstruction Devices Market size is anticipated to be valued at about US$ 12.62 Billion by 2032 end	MARKITWIRED
16-Feb-2023	Intravenous Solution Compounders Market Detailed Survey On Key Trends, Leading Players & Revolutionary Opportunities 2028	MARKITWIRED
16-Feb-2023	Palliative Care Market totaling around US$ 28,518.5 Million by 2032 \| FMI	MARKITWIRED
16-Feb-2023	Aquaculture Therapeutics Market is likely to reach US$ 4190.3 Million by 2032	MARKITWIRED
16-Feb-2023	Large Molecule Bioanalytical Testing Services Market is projected to reach US$ 4.7 Billion by 2033	MARKITWIRED
16-Feb-2023	LIfT BioSciences and Minaris Regenerative Medicine Enter into a Development and Manufacturing Partnership for N-LIfT Allogeneic Neutrophil Based Cell Therapy	B3C newswire
16-Feb-2023	Medartis 2022 full-year results presentation	Medartis Holding AG
16-Feb-2023	Marinomed Biotech AG announces preliminary revenue for 2022 with double-digit growth for Carragelose	Marinomed Biotech AG
16-Feb-2023	Cosmo Pharmaceuticals reports record results for 2022, preliminary results exceeding guidance, increased dividend distribution and 2023 guidance	Cosmo Pharmaceuticals N.V.
16-Feb-2023	saniva diagnostics receives approval from the US FDA for its medical product NeuroMex	Xlife Sciences AG
16-Feb-2023	Newron reports striking one-year interim efficacy results from its Phase II clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia	Newron Pharmaceuticals S.p.A.
16-Feb-2023	Innovation is the Key Benchmark, Focus on Four Healthcare Industry Sub-Sectors in 2023, Says Jafar Wang of Legend Capital	Legend Capital
16-Feb-2023	Clostridium Diagnostics Market is anticipated to secure a market value worth US$ 7.8 Billion by 2032 \| Says FMI Analyst	MARKITWIRED